tiprankstipranks
Talis Biomedical (TLIS)
OTHER OTC:TLIS
US Market

Talis Biomedical (TLIS) Income Statement

Compare
44 Followers

Talis Biomedical Income Statement

Last quarter (Q2 2024), Talis Biomedical's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q2, Talis Biomedical's net income was $-8.85M. See Talis Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 412.00K$ 3.65M$ 0.00$ 10.94M$ 3.98M
Gross Profit
$ 371.00K$ -4.74M$ -2.62M$ 10.94M$ 3.98M
Operating Expenses
$ 67.19M$ 110.40M$ 191.82M$ 91.18M$ 26.70M
Depreciation and Amortization
$ 770.00K$ 11.60M$ 2.62M$ 1.37M$ 726.00K
EBITDA
$ -66.05M$ -106.31M$ -191.82M$ -90.42M$ -25.97M
Operating Income
$ -66.81M$ -115.14M$ -191.82M$ -91.18M$ -26.70M
Other Income/Expenses
$ 4.81M$ 2.13M$ -220.00K$ 54.00K$ -775.00K
Pretax Income
$ -62.01M$ -113.01M$ -192.04M$ -91.13M$ -27.47M
Net Income
$ -62.01M$ -110.89M$ -190.46M$ -91.08M$ -27.43M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -34.12$ -62.45$ -126.13$ -314.06$ -182.88
Diluted EPS
$ -34.12$ -62.45$ -126.13$ -314.06$ -182.88
Weighted Average Shares Outstanding
1.82M 1.78M 1.51M 290.00K 150.00K
Weighted Average Shares Outstanding (Diluted)
1.82M 1.78M 1.51M 290.00K 150.00K
Currency in USD

Talis Biomedical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis